Market News AIOpen the app

PPCB stock news · Propanc Biopharma, Inc.

Stories about Propanc Biopharma, Inc. (PPCB) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PPCB

Follow Propanc Biopharma, Inc. (PPCB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PPCB
Free on the App Store and Google Play, or on the web.
  1. Oct 29, 2026, 7:01 PM ET · Market

    Propanc Biopharma got a warning from Nasdaq that it might be removed from the stock market.

    Bad for PPCB

    Propanc faces Nasdaq removal unless it appeals. Its share price is above $1, but Nasdaq has not confirmed the shortfall is fixed, so the notice is unfavorable for the company.

  2. Oct 29, 2026, 5:51 PM ET · Market

    Propanc Biopharma, Inc. has been told it might be removed from Nasdaq for not meeting price rules.

    Bad for PPCB

    Propanc Biopharma faces possible Nasdaq removal after missing its minimum share-price rule. Its appeal plan and belief it fixed the issue do not erase risks to trading and fundraising.

  3. Oct 23, 2026, 6:20 PM ET · Market

    Propanc Biopharma will combine every 10 shares into 1 to meet Nasdaq rules.

    Neutral

    Propanc approved a 1-for-10 reverse split to help meet Nasdaq's $1 minimum share-price rule. It does not change research progress, so the story leaves its business outlook unchanged.